JVMRX
Price
$30.08
Change
+$0.14 (+0.47%)
Updated
Oct 8 closing price
Net Assets
24.11B
PMVEX
Price
$26.91
Change
+$0.08 (+0.30%)
Updated
Oct 8 closing price
Net Assets
165.78M
Interact to see
Advertisement

JVMRX vs PMVEX

Header iconJVMRX vs PMVEX Comparison
Open Charts JVMRX vs PMVEXBanner chart's image
JHancock Disciplined Value Mid Cap R6
Price$30.08
Change+$0.14 (+0.47%)
VolumeN/A
Net Assets24.11B
PGIM Quant Solutions Mid-Cap Val R2
Price$26.91
Change+$0.08 (+0.30%)
VolumeN/A
Net Assets165.78M
JVMRX vs PMVEX Comparison Chart in %
View a ticker or compare two or three
VS
JVMRX vs. PMVEX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMRX is a Buy and PMVEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMRX has more cash in the bank: 24.1B vs. PMVEX (166M). PMVEX pays higher dividends than JVMRX: PMVEX (1.22) vs JVMRX (0.84). JVMRX was incepted earlier than PMVEX: JVMRX (14 years) vs PMVEX (8 years). PMVEX (25.08) is less costly to investors than JVMRX (0.75). PMVEX is a more actively managed with annual turnover of: 97.00 vs. JVMRX (49.00). PMVEX has a lower initial minimum investment than JVMRX: PMVEX (0) vs JVMRX (1000000). PMVEX annual gain was more profitable for investors over the last year : 8.37 vs. JVMRX (-0.95). PMVEX return over 5 years is better than : 91.81 vs. JVMRX (49.17).
JVMRXPMVEXJVMRX / PMVEX
Total Expense Ratio0.741.2360%
Annual Report Gross Expense Ratio0.7525.083%
Fund Existence14 years8 years-
Gain YTD11.1369.109122%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets24.1B166M14,518%
Annual Yield % from dividends0.841.2269%
Returns for 1 year-0.958.37-11%
Returns for 3 years29.9244.8767%
Returns for 5 years49.1791.8154%
Returns for 10 years54.96N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECEMX17.03N/A
N/A
Parametric Emerging Markets C
LGPSX41.20N/A
N/A
ProFunds Large Cap Growth Svc
ITCTX26.37N/A
N/A
VY® T. Rowe Price Capital Apprec S2
BRXCX16.50N/A
N/A
MFS Blended Research Intl Eq C
WENRX67.79N/A
N/A
Allspring Mid Cap Growth Fund - Cl R6